FAM120A: A Potential Drug Target and Biomarker (G23196)

Target Name: FAM120A

NCBI ID: G23196

FAM120A

FAM120A: A Potential Drug Target and Biomarker

FAM120A, also known as DNA polymerase-transactivated protein 5, is a gene that encodes a protein that plays a crucial role in the process of DNA replication and transcription. The protein is expressed in various tissues and cells of the body, including the nervous system, and has been implicated in a number of biological processes, including the regulation of cell growth, differentiation, and survival.

Recent studies have suggested that FAM120A may have potential as a drug target or biomarker. In this article, we will explore the potential implications of FAM120A as a drug target and biomarker, as well as its potential therapeutic applications.

Potential Drug Target

One of the most promising aspects of FAM120A as a drug target is its involvement in the regulation of cell growth and survival. Several studies have suggested that the protein plays a role in the regulation of cell proliferation and that its levels may be associated with the development of cancer.

In addition, FAM120A has been shown to be involved in the regulation of cell survival, as well as the response to stress and chemotherapy. These findings suggest that FAM120A may be a useful target for drugs that are designed to inhibit its activity and reduce the risk of cancer or other diseases.

Potential Biomarker

Another potential use for FAM120A is as a biomarker for a variety of diseases, including cancer. The protein is expressed in various tissues and cells of the body, including the nervous system, and has been shown to play a role in the regulation of neural development and function.

Studies have suggested that changes in the levels of FAM120A may be associated with the development of certain diseases, including cancer. Additionally, the protein has been shown to be involved in the regulation of cell death, which may be a useful biomarker for diseases that are characterized by cellular dysfunction or death.

The Potential therapeutic applications of FAM120A as a drug target or biomarker are vast and continue to be explored by researchers. In the future, studies are likely to provide more insights into the role of FAM120A in various biological processes and its potential as a drug target or biomarker.

Conclusion

In conclusion, FAM120A is a gene that has been shown to play a role in a variety of biological processes, including the regulation of cell growth, differentiation, and survival. Recent studies have suggested that the protein may have potential as a drug target or biomarker, and further research is needed to fully understand its role in these processes.

If you liked this prompt, please like it on the prompt search page so we know to keep enhancing it.

Protein Name: Family With Sequence Similarity 120A

Functions: May participate in mRNA transport in the cytoplasm (By similarity). Critical component of the oxidative stress-induced survival signaling. Activates src family kinases and acts as a scaffolding protein enabling src family kinases to phosphorylate and activate PI3-kinase. Binds RNA and promotes the secretion of IGF-II. May play a pivotal role in the progression of scirrhous-type gastric cancer by supporting cancer cell survival in environments with various oxidative stresses

The "FAM120A Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about FAM120A comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets